Dr. Jay Lombard, a neurologist, is the co-founder and chief scientific officer of Genomind (Chalfont, Pennsylvania), a company focused on improving the lives of patients with psychiatric and neurological conditions through biomarker discovery. Lombard has researched and developed several novel therapeutic interventions to treat depression, dementia, and autism.
Nachum (Homi) Shamir is president/CEO of Given Imaging (Yokneam, Israel), whose U.S. operations are located in Duluth, Georgia. Shamir joined the company in April 2006, prior to which he served as corporate VP of Eastman Kodak and as president of Eastman Kodak's Transaction and Industrial Solutions Group, which includes several business units, among them Kodak Versamark (whose operations were previously those of Scitex Digital Printing), of which he was president/CEO. From June 2003-January 2004, he was president/CEO of Scitex Corp., and before Scitex held senior management positions at various international companies, mainly in the Asia-Pacific regions.
Nachum (Homi) Shamir is president/CEO of Given Imaging (Yokneam, Israel), whose U.S. operations are located in Duluth, Georgia. Shamir joined the company in April 2006, prior to which he served as corporate VP of Eastman Kodak and as president of Eastman Kodak's Transaction and Industrial Solutions Group, which includes several business units, among them Kodak Versamark (whose operations were previously those of Scitex Digital Printing), of which he was president and CEO. From June 2003-January 2004, he was president/CEO of Scitex Corp., and before Scitex held senior management positions at various international companies, mainly in the Asia-Pacific regions.
Ateev Mehrotra, MD, joined the faculty of the University of Pittsburgh in 2006. He is an associate professor of medicine in the Division of General Internal Medicine. Mehrotra also is a health policy researcher with RAND Corp. His research focuses include the measurement and public reporting of healthcare quality and efficiency, pay-for-performance incentives, and consumer-directed healthcare.
Ateev Mehrotra, MD, joined the faculty of the University of Pittsburgh in 2006. He is an associate professor of medicine in the Division of General Internal Medicine. Mehrotra also is a health policy researcher with RAND Corp. His research focuses include the measurement and public reporting of healthcare quality and efficiency, pay-for-performance incentives, and consumer-directed healthcare.
Marc Dubreuil is director of business development at Farm, a Hollis, New Hampshire-based product development firm that focuses on medical and life sciences. He has held numerous positions within the plastics and manufacturing industries, and has a strong background in the product development process.
Marc Dubreuil is director of business development at Farm, a Hollis, New Hampshire-based consultancy that focuses on medical and life sciences product development. He has held numerous positions within the plastics and manufacturing industries, and has a strong background in the product development process.
Waleed Hassanein, MD, is president, CEO and a director of TransMedics (Andover, Massachusetts). He founded the company in 1998 and led it through the clinical development, market launch and commercial rollout of the breakthrough Organ Care System (OCS) technology. The OCS is a medical device used for ex-vivo physiologic preservation and assessment of transplantable organs, in both the European and U.S. markets.
Christopher Molineaux is president of Pennsylvania Bio, the only statewide trade association for the life sciences industry whose membership includes medical device, diagnostic, biotechnology, pharmaceutical and research organizations. Prior to joining Pennsylvania Bio in September 2009, he served as worldwide vice president of pharmaceutical communication and public affairs for Johnson & Johnson.